Get Live Data

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Cambridge Cog Share Price
  4. Cambridge Cog Share Regulatory News
  5. Appointment of Joint Broker

Pin to quick picksCambridge Cog Regulatory News (COG)

Cambridge Cog Information

Share Price Information for Cambridge Cog (COG)

Share Price is delayed by 15 minutes
Get Live Data
33.50    0.50 (1.52%)
Bid:
32.00
Ask:
35.00
Spread: 3.00 (9.375%)
Market Cap: £18.03m
COG Live PriceLast checked at - London Stock Exchange

Intraday Cambridge Cog Share Chart

Appointment of Joint Broker

20 Feb 2017 07:00

RNS Number : 1878X
Cambridge Cognition Holdings PLC
20 February 2017
 

20 February 2017

 

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

 

Appointment of Joint Broker

 

The neuroscience digital health company Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG) announces that Dowgate Capital Stockbrokers Limited has been appointed as Joint Broker to the Company, with immediate effect. finnCap Ltd remains the Company's Nominated Adviser and Joint Broker.

 

Enquiries

 

Cambridge Cognition Holdings PLC

Steven Powell, Chief Executive Officer

Noah Konig, Director of Marketing and Communications

 

Tel: 01223 810 700

press@camcog.com

finnCap Ltd (NOMAD and Joint Broker)

Geoff Nash / Simon Hicks

Alice Lane

Tel: 020 7220 0500

(Corporate Finance)

(Corporate Broking)

Dowgate Capital Stockbrokers Limited

David Poutney / James Serjeant

Tel: 01293 517 744

 

 

Notes to editors

 

About Cambridge Cognition Holdings PLC

Cambridge Cognition is a neuroscience digital health company specialising in the precise measurement of clinical outcomes in neurological disorders. The Company develops and markets validated near patient assessment products using cognition as a biomarker to improve understanding, diagnosis and treatment in brain health worldwide.

Partners include the world's leading drug development companies, academic institutions and public-private health organisations.

www.cambridgecognition.com @CANTABconnect press@camcog.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPGCGDDBUBBGRR
12345678
Date   Source Headline
30th Jun 20267:00 amRNSResult of Retail Offer
24th Jun 20267:01 amRNSRetail Offer
24th Jun 20267:00 amRNSResult of Placing & Posting of Circular
23rd Jun 20264:35 pmRNSProposed Equity Fundraising and Retail Offer
1st Jun 20267:00 amRNS-RCOG to present at Mello 2026
28th May 20261:15 pmRNSLaunch of brain health study with Oura
21st May 20262:50 pmRNSResult of AGM
24th Apr 20263:16 pmRNSPosting of Annual Report & Notice of AGM
13th Apr 20267:00 amRNSResults for the year ended 31 December 2025
7th Apr 20267:01 amRNSNotice of Results
7th Apr 20267:00 amRNSAppointment of Nominated Adviser and Joint Broker
1st Apr 20267:00 amRNSBlock Listing Return
11th Mar 20267:00 amRNSMonument Therapeutics MT1988 First Patient Dosed
11th Mar 20267:00 amRNSMonument Therapeutics MT1988 First Patient Dosed
16th Feb 20267:00 amRNSCommercialisation Agreement
9th Feb 20267:00 amRNSChange of Joint Broker
19th Jan 20267:00 amRNSTrading Update
5th Nov 20257:01 amRNSChange of Auditor
5th Nov 20257:00 amRNSBoard Updates
1st Oct 20257:00 amRNSBlock Listing Return
29th Sep 20257:00 amRNSExercise of Options and Total Voting Rights
26th Sep 20259:59 amRNSHolding(s) in Company
8th Sep 20257:00 amRNSHolding(s) in Company
5th Sep 20252:51 pmRNSHolding(s) in Company
5th Sep 202512:04 pmRNSHolding(s) in Company
2nd Sep 20255:21 pmRNSHolding(s) in Company
1st Sep 202510:58 amRNS-RInvestor Presentation via Investor Meet Company
28th Aug 202510:45 amRNS£1.12m Placing & Subscription, TVR & PDMR Dealings
28th Aug 20257:01 amRNSChanges to Board and Management
28th Aug 20257:00 amRNSInterim Results
19th Aug 202510:10 amRNS-RMonument Therapeutics Partnership with FNIH
12th Aug 20257:00 amRNSLaunch of Speaker Identification Solution
31st Jul 20257:00 amRNSTrading update for period ended 30 June 2025
27th Jun 202512:27 pmRNSResult of AGM
24th Jun 20257:00 amRNS-RMonument Therapeutics Success in Phase I Results
4th Jun 20257:00 amRNSNotice of AGM
6th May 20255:59 pmRNSHolding(s) in Company
1st May 20257:00 amRNSPreliminary Unaudited Results
24th Apr 20257:00 amRNSNotice of Results and Investor Presentation
10th Apr 20257:00 amRNSContract Win
7th Apr 202510:24 amRNSHolding(s) in Company
3rd Apr 20257:00 amRNSContract Win
1st Apr 20257:00 amRNSBlock Listing Return
6th Mar 20257:00 amRNS-RCANTAB® used for major global brain health study
18th Feb 20257:00 amRNS-RCambridge Cognition submits FDA Letter of Intent
7th Feb 20257:00 amRNSBoard Appointment
21st Jan 20257:00 amRNSLaunch of in-house rater training service
16th Jan 20257:00 amRNSExpanded partnership with Actinogen
27th Dec 20243:34 pmRNSDirector/PDMR Share Purchases
23rd Dec 20244:02 pmRNSDirector/PDMR Share Purchases
12345678

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
MA47
Citi Fun 26
LSE
0.00%
BOOM
Audioboom Grp.
LSE
-3.23%
D4T4
D4T4.L
LSE
0.00%
IGAS
IGAS.L
LSE
0.00%
HUI
Hydrogen Utopia
LSE
0.00%
Trending
HEX
Helix Exploration
LSE
-7.88%
EUA
Eurasia Mining
LSE
0.00%
GGP
Greatland Resources
LSE
0.92%
EZJ
easyJet
LSE
0.04%
HE1
Helium One
LSE
-3.76%